Form 4: Tandem Diabetes Care Executive Granted RSUs
Insider Transaction Report
Susan Morrison, EVP & Chief Admin. Officer of Tandem Diabetes Care, received 29,136 Restricted Stock Units on May 29, 2026.
Summary
- Susan Morrison, Executive Vice President and Chief Administrative Officer of Tandem Diabetes Care Inc., was granted 29,136 Restricted Stock Units (RSUs) on May 29, 2026.
- These RSUs represent a contingent right to receive either one share of the company's common stock or cash in lieu thereof.
- Vesting of these RSUs is scheduled, with one-third vesting on May 29, 2027, and the remainder vesting in eight equal quarterly installments thereafter.
- This transaction is filed under Section 16(a) of the Securities Exchange Act of 1934, indicating changes in beneficial ownership by an insider.
- A substitute Power of Attorney was also filed, appointing Jerilyn Laskie as an attorney-in-fact for various individuals, including Susan Morrison, to execute and file documents with the SEC.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports on routine executive compensation in the form of RSUs and a power of attorney, without providing new financial performance data or strategic shifts.
Positives
- Grant of Restricted Stock Units (RSUs) to a key executive, indicating a commitment to long-term incentive and retention.
- Clear vesting schedule provides visibility into future share issuance and potential dilution.
- The filing is compliant with SEC regulations, ensuring transparency in insider transactions.
Risks
- Potential for future share price impact due to the vesting and potential issuance of 29,136 shares.
- The RSUs are subject to the terms of the 2023 Long-Term Incentive Plan, which may include performance or continued employment conditions not detailed in this filing.
Future Outlook
The filing details the vesting schedule for 29,136 RSUs granted to Susan Morrison, with initial vesting on May 29, 2027, and subsequent quarterly vesting thereafter. This indicates a structured approach to executive compensation and potential future share issuance.
Industry Context
StockSavvy.ai notes that the issuance of Restricted Stock Units (RSUs) is a common practice in the medical device industry, particularly for companies like Tandem Diabetes Care, to attract, retain, and incentivize key executives by aligning their interests with shareholders through long-term equity awards.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Delegation | Shannon M. Hansen, as attorney-in-fact for several individuals including Susan M. Morrison, has appointed Jerilyn Laskie as a substitute attorney-in-fact to execute and file SEC documents. | 05/20/2026 | Ensures continued compliance with SEC filing requirements for beneficial ownership changes, even in the absence of the primary attorney-in-fact. |
Stakeholder Impact
- Shareholders: Potential for slight dilution upon vesting and exercise of RSUs, but also aligns executive interests with long-term company performance.
- Employees: Reinforces the company's use of equity-based compensation for executive retention.
- Management: Susan Morrison receives a long-term incentive award.
Next Steps
- Vesting of one-third of RSUs on May 29, 2027.
- Subsequent quarterly vesting of remaining RSUs thereafter.
- Potential issuance of common stock or cash in lieu thereof upon vesting, at the Issuer's discretion.
Key Dates
| Date | Description |
|---|---|
| 04/19/2022 | Date of Power of Attorney for Dick P. Allen, Elizabeth A. Gasser, Kathleen McGroddy-Goetz, Rajwant S. Sodhi, Christopher J. Twomey. |
| 04/20/2022 | Date of Power of Attorney for Peyton R. Howell, Rebecca B. Robertson, John F. Sheridan, Leigh A. Vosseller. |
| 04/21/2022 | Date of Power of Attorney for Ricky A. Carpenter, Jean-Claude Kyrillos, Susan M. Morrison, Myoungil Cha. |
| 06/15/2022 | Date of Power of Attorney for Joao Malagueira, Myoungil Cha. |
| 06/21/2024 | Date of Power of Attorney for Jean-Claude Kyrillos. |
| 11/11/2025 | Date of Power of Attorney for Sandra W. Beaver. |
| 05/29/2026 | Transaction Date: Grant of Restricted Stock Units to Susan Morrison. |
| 05/20/2026 | Execution date of the Substitute Power of Attorney by Shannon M. Hansen. |
| 05/29/2027 | First vesting date for one-third of the RSUs granted to Susan Morrison. |
Keywords
Tandem Diabetes Care, TNDM, Form 4, Insider Transaction, Restricted Stock Units, RSU, Executive Compensation, Beneficial Ownership, SEC Filing, Vesting Schedule
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.